Yale Cancer Center
Avatar

GI Oncology Year in Review: Precision Medicine Update in Metastatic Pancreatic Cancer

By Yale Cancer Center FEATURING Jill Lacy
By Yale Cancer Center FEATURING Jill Lacy
0 views
March 13, 2024
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
07:37
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pem…

Feat. B. Weinberg
04:25
ecancer

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…

Feat. J. Knox
10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
18:35
Rachna Shroff

Augmenting Standard Treatment Options in Pancreatic Cancer

06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

Feat. Z. Wainberg
08:03
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 …

Feat. Z. Wainberg
23:32
The University of Kansas Cancer Center

Updates on Pancreatic Cancer Treatment

Feat. A. Kasi
09:16
Total Health

Clinical Implications & Highlights of Recent Pancreatic Cancer T…

Feat. J. Kratz
07:11
Total Health

ASCO 2022 Non-Colorectal Cancer Updates

Feat. D. Catenacci
33:28
ecancer

ESMO 2022: Highlights, Commentary, and Analysis of the Key Studies

Feat. B. Gyawali
08:23
Total Health

Updates in the SoC for 1L Pancreatic Adenocarcinoma

Feat. T. Heumann